Key Findings
The Europe pharmaceutical desiccant market is anticipated to rise at a CAGR of 4.60% over the estimated period 2019-2027. The Europe market is thriving owing to wide applications of pharmaceutical desiccants in range of industry verticals like chemical, pharmaceuticals, biohazard, environmental clean-up, liquid & gas, and others.

Market Insights
Europe region provides one of the largest markets for pharmaceutical desiccants. The market is evolving significantly because of factors like increasing utilization of pharmaceutical desiccant in treating nuclear waste and the tremendous availability of natural pharmaceutical desiccant in Turkey and Russia. The key countries present in the Europe region are UK, France, Germany, Spain, Italy, and Rest of Europe that comprises of remaining European countries. Amongst all, the advanced healthcare system in the countries of Germany, France, and the UK is providing the growth potential for the pharmaceutical desiccant market. Also, the flourishing pharmaceuticals industry in the region because of the rising R & D investments and innovation further surge the demand for pharmaceutical desiccant, in turn, driving its market growth. However, the implementation of rigorous regulations is one of the major factor that restricts market growth in this region.

Competitive Insights
The renowned players in the market are E. I. du Pont de Nemours and Company, Desiccare Inc., Proflute AB, W. R. Grace & Co., CSP Technologies Inc., Sanner GmbH, Rotor Source Inc., Munters AB, Oker-Chemie GmbH, and Multisorb Technologies. The companies follow numerous corporate strategies to hold a strong position in the market.